Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.750
0.00 (0.00%)
Feb 3, 2026, 9:44 AM CET
84.47%
Market Cap1.68B +113.3%
Revenue (ttm)100.00K
Net Income-58.91M
EPS-0.22
Shares Out354.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume319,846
Average Volume1,275,141
Open4.755
Previous Close4.750
Day's Range4.730 - 4.825
52-Week Range1.804 - 5.450
Beta0.14
RSI46.83
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 13
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements